Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegneugen in chemotherapy-induced neutropenia
NCT04466137Phase 3Completed
- Sponsor
- Xiamen Tebao Biological Engineering Co., Ltd.
- Start
- Oct 2020
- Primary completion
- Jun 2021
- Modality
- PEGylated Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of topegfilgrastim in febrile neutropenia (FN), sponsored by Xiamen Tebao Biological Engineering Co., Ltd.. Started Oct 2020; status: completed.
02
Drugs
topegfilgrastim
03
Conditions
febrile neutropenia (FN)
Beyond the preview
Go deeper on NCT04466137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04466137.